Nine medical device companies are entering the A-share market

Pharmaceutical Network November 20 hearing as of November 17, 2017, a total of 9 medical device companies are entering the A-share market, China's medical device A-share listed companies, is likely to increase a few more.

And in these enterprise Among them, the most likely to take the lead in landing A shares of Shenzhen's new industries, has now entered the pre-disclosure links; Chongqing is currently in the state of suspended health products is suspended, is an unknown.

The rest of the enterprises, the majority have still been accepted, the state has been feedback, but also to queue for some time to enter the haircut.

Among them, the industry generally pay attention to the Shenzhen Mindray, after the large genetic city breakthrough 100 billion, it was once expected Mindray once landed A-share market, there may be hundreds of billions of market value of the enterprise.

In March last year, Mindray just delisted from the United States NYSE at that time, Cyberjaya instruments had analyzed that it should be to return to the A-share market.

Enterprises to grow and develop, no doubt need the power of capital.In the current, medical instruments Market prospects are generally optimistic, although the output value in this area is far worse drug , But in the capital market, the average share price and average price-earnings ratio point of view, should be higher than the drugs.